FDA approves new treatment for certain advanced or metastatic breast cancers

By Newsroom America Feeds at 28 Sep 2017

The U.S. Food and Drug Administration today approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer that has progressed after taking therapy that alters a patient’s hormones (endocrine therapy).

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm578071.htm

Categories:
Tags:

[D] [Digg] [FB] [R] [SU] [Tweet] [G]

NEWSMAIL